a public good project by the
Synthesis
Company
of California

© 2026

Deng-Shuang Wu | doi.page

0 works0 citations0 h-index

Deng-Shuang Wu

Qingdao University(CN)Shandong University(CN)Qingdao Municipal Hospital(CN)Shandong Provincial QianFoShan Hospital(CN)

Publications by Year

Research Areas

Cancer-related molecular mechanisms research, Renal cell carcinoma treatment, MicroRNA in disease regulation, Ferroptosis and cancer prognosis, Renal and related cancers

Most-Cited Works

→ Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA(2016)1,160 cited
→ Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling(2017)256 cited
→ Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma(2016)118 cited
→ A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells(2016)111 cited
→ Chemical influences on the specificity of tyrosine phosphorylation.(1990)100 cited
→ ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma(2016)52 cited

→ KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma(2017)

40 cited

→ Diameter-Axial-Polar Nephrometry is Predictive of Surgical Outcomes Following Partial Nephrectomy(2015)7 cited

→ SLC9A1 Binding mTOR Signaling Pathway-Derived Risk Score Predicting Survival and Immune in Clear Cell Renal Cell Carcinoma(2023)

→ Additional file 1: Table S1. of Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling(2017)